AzTrials
AzTrials

Incisional HerniaPHITNCT04699201

Trocar Site Incisional Hernia Prevention

A study testing Hincisional hernia prevention by onlay prosthesis trocar closure, laparoscopic cholecystectomy and Abdominal ultrasound in people with Incisional Hernia, run by Hospital Universitari Joan XXIII de Tarragona. at 2 sites in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Objective: To test the preventive effect of the placement of an onlay mesh versus the use of a fascial closure device at the umbilical trocar site closure in order to prevent incisional hernia after laparoscopic surgery. Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Incisional Hernia
What is being tested?
Hincisional hernia prevention by onlay prosthesis trocar closure, laparoscopic cholecystectomy and Abdominal ultrasound
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
94 participants
Where
2 sitesSpain
Study dates
2 Mar 2021to Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients undergoing elective laparoscopic cholecystectomy, with or without an exploration of the common bile duct, undergoing surgery in our hospital
  • ASA (American Society of Anesthesiologists) <IV

Who cannot join

  • Allergy or intolerance to any of the mesh components
  • Patients presenting already primary or incisional hernia of the abdominal wall
  • ASA ≥IV
  • Intraoperative conversion to laparotomy
  • Emergency surgery
  • Pregnancy

Trial locations and contacts

2 sites in 1 country.

Joan Ferreres Serafini, MD contact

(+34) 657920793

joanfs8@gmail.com

Rosa Jorba Martin, MD contact

rjorba.hj23.ics@gencat.cat

Spain2 sites, 2 recruiting
  • Hospital Universitari de Tarragona Joan XXIII

    Tarragona, Tarragona, 43005

    Joan Ferreres Serafini, MD, 657920793, joanfs8@gmail.com

    Recruiting
  • Pius, Hospital de Valls

    Valls, Tarragona, 43800

    Joan Ferreres Serafini, MD, 657920793, joanfs8@gmail.com

    Recruiting

Other trials in Spain

About this study

Official title: Prevenció De L'Hèrnia Incisional Per Tròcar

Objective: To test the preventive effect of the placement of an onlay mesh versus the use of a fascial closure device at the umbilical trocar site closure in order to prevent incisional hernia after laparoscopic surgery.

Methods: We designed a Two Center Randomized Controlled Trial were adult participants presenting for elective laparoscopic cholecystectomy, with or without an exploration of the common bile duct will be recruited, with allocation of each of them in 2 groups (prosthesis and control). Abdominal ultrasound scan focused on aponeurosis defects at the trocar sites will be performed at 12 postoperative months.

Read more

An ultrasound scan will be performed to avoid underdiagnosis bias since incisional hernia is frequently under detected by clinical examination.

Relevance: The prevalence of incisional hernia after laparoscopy might be as high as 30%, due to this reason is paramount to find a better closure technique.

There are few studies about incisional hernia including radiological exams in order to provide the exact prevalence of this pathology, even fewer literature exists about incisional hernia after laparoscopic procedures.

Read the detailed description

OBJECTIVE To test the preventive effect of the placement of an onlay mesh at the time of umbilical trocar site closure in order to prevent incisional hernia after laparoscopic surgery.

The estimated prevalence of incisional hernia after laparoscopy is 15- 25%, being even higher among patients with risk factors. Many different closure techniques exist, however few of them have been tested in Randomised Control Trials. Most of them lack an image technique to provide more accurate results.

METHODOLOGY

We designed a Two Center, Randomized Controlled Trial that will enroll patients undergoing laparoscopic cholecystectomy, with or without an exploration of the common bile duct. Participants will be randomized to 2 groups. The pneumoperitoneum technique will be achieved by Hasson technique. The closure procedure will take place at the end of the surgery, after the cholecystectomy is performed:

  • Prosthesis: after suturing the aponeurosis with a J needle and 0 Polydioxanone, a lightweight, large-pore mesh made of PVDF monofilament (polyvinylidene fluoride - DynaMesh-CICAT, FEC Textiltechnik, Germany) will be placed onlay, overlapping 2cm in all directions from the edge of the aponeurosis incision at the umbilical trocar site. The mesh will be fixed to the aponeurosis with cyanoacrylate glue (Glubran®, GEM, Viareggio, Italy).
  • Control: Closure of the aponeurosis will be performed by standard procedure: under direct vision, suturing the aponeurosis with a J needle and 0 Polydioxanone, with a stitch interval of ≤ 5mm.

An abdominal ultrasound scan focused on aponeurosis defects at the trocar sites will be performed at 12 postoperative months. Minimum follow-up will be 12 months.

All the adverse events will be registered and classified according to the Clavien Dindo classification.

An ultrasound scan will be performed to avoid underdiagnosis bias since incisional hernia is frequently under detected by clinical examination.

Relevance: The prevalence of incisional hernia after laparoscopy might be as high as 30%, due to this reason is paramount to find a better closure technique.

There are few studies about incisional hernia including radiological exams in order to provide the exact prevalence of this pathology, even fewer literature exists about incisional hernia after laparoscopic procedures.

Univariate descriptive analysis will present the results as means (with standard deviation and range) for the continuous variables and as numbers and percentages for the categorical variables. Bivariate analysis will be carried out among the variables of interest to describe their level of correlation and evaluate the possible differences between them. To evaluate the differences between the continuous variables we will use the comparison of means based on the T-Student and for the comparison of categorical variables the Chi-square test. Finally, linear regression models and generalized linear models (as appropriate depending on the response variable) will be used to study the dependence of the variables of interest, with other factors of study. Statistical analysis will be carried out using the SPSS (Statistical Package for the Social Sciences) Software (IBM SPSS Statistics 23). All tests will be bilateral with a level of significance of 5%. 100% of the data recorded will be analyzed, and the proportion of values lost in the variables of interest will be evaluated.

Being tested
Hincisional hernia prevention by onlay prosthesis trocar closure, laparoscopic cholecystectomy, Abdominal ultrasound
Keywords
Incisional Hernia, Umbilical Trocar, Preventive mesh
Medical subject headings
Incisional Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hincisional hernia prevention by onlay prosthesis trocar closureProcedure or surgery

    Hincisional hernia prevention by onlay prosthesis trocar closure

  • laparoscopic cholecystectomyProcedure or surgery

    Laparoscopic cholecystectomy with or without common bile duct exploration

  • Abdominal ultrasoundDiagnostic test

    Ultrasound focused in abdominal wall defects on the trocar incisions, 12 months after the surgery

Study groups in NCT04699201
Study groupRoleWhat they receive
ProsthesisExperimentalFirstly, a laparoscopic cholecystectomy is performed. After suturing the aponeurosis with a J needle and 0 Polydioxanone, a lightweight, large-pore mesh made of PVDF monofilament (polyvinylidene fluoride - DynaMesh-CICAT, FEC Textiltechnik, Germany) will be placed onlay, overlapping 2cm in all directions from the edge of the aponeurosis incision at the umbilical trocar site. The mesh will be fixed to the aponeurosis with cyanoacrylate glue (Glubran®, GEM, Viareggio, Italy).
Receives: Procedure: Hincisional hernia prevention by onlay prosthesis trocar closure; Procedure: laparoscopic cholecystectomy; Diagnostic Test: Abdominal ultrasound
ControlActive comparatorFirstly, a laparoscopic cholecystectomy is performed. Closure of the aponeurosis will be performed by standard procedure: under direct vision, suturing the aponeurosis with a J needle and 0 Polydioxanone, with a stitch interval of ≤ 5mm.
Receives: Procedure: laparoscopic cholecystectomy; Diagnostic Test: Abdominal ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of incisional hernia

    The primary endpoint is the incidence of incisional hernia in the 2 groups. Because incisional hernia may occur within the first months after surgery, assessment will be carried out during scheduled clinical visits over 12 months. The presence of incisional hernia will be evaluated by physical examination and radiologically by an abdominal US scan performed at the end of follow-up (12 months after operation).

    Measured: 12 months

Secondary outcomes (2)
  1. Perioperative complications

    Secondary endpoints will be perioperative complications, including wound infection, haematoma, pain and reoperation.

    Measured: 30 days

  2. Economical impact

    We will compare on one side the cost of the mesh and the glue and on the other side the costs of reoperation and hospital stay in case of appearance of incisional hernias.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2021
  2. Study start2 Mar 2021
  3. Primary completionNov 2024 (estimated)
  4. Study completionFeb 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Bicentric Randomized Controlled Trial. 2 allocation groups, parallel. Single blind. Enrollment: consecutive cases Time Perspective: Prospective
Masking
Single blind
Who is masked
Participant
Enrolment
94 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04699201
Sponsor's protocol ID
156/2020
Acronym
PHIT
Status last verified
Oct 2024
First submitted
6 Jan 2021
Last updated
2 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Hincisional hernia prevention by onlay prosthesis trocar closure, laparoscopic cholecystectomy and Abdominal ultrasound in people with Incisional Hernia, run by Hospital Universitari Joan XXIII de Tarragona. at 2 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Joan Ferreres Serafini, MD ((+34) 657920793, joanfs8@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of incisional hernia (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in